Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
NCT00317980
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
280
Enrollment
OTHER
Sponsor class
Conditions
Cutaneous Leishmaniasis
Interventions
DRUG:
Meglumine antimoniate
DRUG:
Meglumine antimoniate
Sponsor
University of Brasilia
Collaborators
[object Object]